However his preparation for the Italian race was hampered after breaking

However, his preparation for the Italian race was hampered after breaking his collarbone in a crash in March.The 37-year-old Texan also wished to be closer to his family, with his partner last month giving birth to a son, Maxwell — Armstrong’s fourth child.For a change, Armstrong will not have a whole team dedicated to him, as Spaniard Alberto Contador, the race’s hot favorite, has been named Astana’s leader on the Tour.Fans, critics and pundits should however have a first indication of Armstrong’s form when he starts his French campaign at 10:17 a.m. We have had a different program either of necessity or because of (Lance’s) choice to favor his personal life,” Bruyneel told a news conference.”We are a bit lost and I really do not know what to expect.”Armstrong, who returned to racing in January after 3 1/2 years in retirement, used to focus only on the Tour but took part in the Giro for the first time this year. MONACO (Reuters) – There are still doubts as to how Lance Armstrong will perform on the Tour de France, Astana team manager Johan Bruyneel said on Friday. Sports  |  France  |  ItalyBruyneel, the man behind the American’s seven Tour titles from 1999 to 2005, said Armstrong’s program was so different to the one he followed in his prime that it was almost impossible to tell what would happen when the race starts on Saturday.”We are a bit struggling for reference marks.

For more information, go to http:// SOURCEUniversity of North Texas Health Science Center/Fort WorthDana Benton Russell, ABC, University of North Texas Health Science Center/FortWorth, +1-817-735-2446, . “Fort Worth’s medical school and more” contributesmore than $400 million to the Tarrant County and Texas economies annually. Keyresearch areas include aging and Alzheimer’s disease, cancer and physicalmedicine.This year, the Texas College of Osteopathic Medicine was named atop 50 medical school in primary care by U.S News & World Report for theeighth consecutive year. These current studies of the effects of rapid estrogenadministration on patients with traumatic brain injury and hemorrhagic shockwill be a test of this proposal.

In 1994, Simpkins discovered that estrogens were protective to nerve cells andsubsequently has demonstrated that, if administered soon after brain injury inanimals, estrogens can protect nerve cells and reduce neurological deficits.Application of these discoveries to human subjects awaited the interactions ofSimpkins with the pioneering clinical research of Wigginton, who is now thefirst to take estrogens into clinical trials for acute brain injury andhemorrhagic shock.University of North Texas Health Science CenterThe University of North Texas Health Science Center comprises the TexasCollege of Osteopathic Medicine, the Graduate School of Biomedical Sciences,the School of Public Health, and the School of Health Professions. Prior studies have suggested that young women are more resistant tobrain trauma injury than are older, post-menopausal women and men. Thisapparent resistance of young women to brain trauma may be because of theirhigher estrogen levels. This is the first major clinical study to emanate fromthese basic science studies at the University of North Texas Health ScienceCenter at Fort Worth.Estrogens are made in large amounts by young women, but only in small amountsby men. Simpkins leads a large National Institutes ofHealth-funded program of research to discover substances that can protect thebrain from injury. The clinical trials are based on now hundreds of scientific publications fromSimpkins’ group and others demonstrating the protective effects of estrogensin acute brain injury. “We know these substances can protect the brain and believe themsafe for use in this patient population,” Simpkins said.